LB PHARMACEUTICALS INC
Q4 2025 13F Holders
Symbol
LBRX
CUSIP
50180M108
Type
Equity
Class
COM SHS
Num filings
68
Total reported value, excl. options
$552 M
Compare 2025 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q3
Manager
Report Date
Value ($000)
Shares
Option Type